Hiroo Yoshikawa
Hiroo Yoshikawa publishes mostly in Neurology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Hereditary Neurological Disorders, Peripheral Neuropathies and Disorders and Genetic Neurodegenerative Diseases.
- World rank
- #1,717,004 of 7,710,434 ranked researchers
- Rank in Japan
- #29,088 of 383,136
- Works
- 111
- Citations
- 4.5k
- Citations per work
- 40.9
What does Hiroo Yoshikawa research?
Hiroo Yoshikawa's work is mostly in Medicine (25%), Neuroscience (23%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4540.1%
- Life Sciences3935.1%
- Neuroscience2522.6%
- Biochemistry, Genetics and Molecular Biology1412.5%
- Health Sciences2824.8%
- Medicine2824.8%
- 1Neurology18% of their works
- 2Molecular Biology12% of their works
- 3Cellular and Molecular Neuroscience12% of their works
- 4Physiology7% of their works
- 5Neurology7% of their works
- 6Developmental Neuroscience4% of their works
Research topics
- Hereditary Neurological Disorders
- Peripheral Neuropathies and Disorders
- Genetic Neurodegenerative Diseases
- Neurogenesis and neuroplasticity mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
- Neuroinflammation and Neurodegeneration Mechanisms
- Multiple Sclerosis Research Studies
Which keywords describe Hiroo Yoshikawa's research?
The keywords of their largest research topics: Mitochondrial Dysfunction, Neurological Disorders, Treatment, Brain Development, Diagnostic Criteria, Neurodegeneration, Charcot-Marie-Tooth Disease and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
- Neuromyelitis Optica
- Multiple Sclerosis
- Neurotoxins
- a-Synuclein
- Protein Aggregation
- Huntington's Disease
- Hereditary Spastic Paraplegia
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Neurodegeneration
- Brain Development
- Neurological Disorders
- Mitochondrial Dysfunction
- Treatment
- Diagnostic Criteria
- Charcot-Marie-Tooth Disease
- Guillain-Barré Syndrome
- Adult Stem Cells
- Neurogenesis
- Parkinson's Disease
- Botulinum Toxin
- Microglia
- Neuroinflammation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Mitochondrial Dysfunction383 topics
- Neurological Disorders252 topics
- Treatment252 topics
- Brain Development202 topics
- Diagnostic Criteria192 topics
- Neurodegeneration192 topics
- Charcot-Marie-Tooth Disease151 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy151 topic
- Guillain-Barré Syndrome151 topic
- Hereditary Spastic Paraplegia151 topic
- Adult Stem Cells121 topic
- Huntington's Disease121 topic
- Neurogenesis121 topic
- Protein Aggregation121 topic
- Parkinson's Disease111 topic
- a-Synuclein111 topic
- Botulinum Toxin101 topic
- Neurotoxins101 topic
- Microglia81 topic
- Multiple Sclerosis81 topic
- Neuroinflammation81 topic
- Neuromyelitis Optica81 topic
Where does Hiroo Yoshikawa work?
Hiroo Yoshikawa's main affiliation in the publication record is Hyogo Medical University, Japan.
How many publications and citations does Hiroo Yoshikawa have?
OpenAlex counts 111 works and 4,542 citations for Hiroo Yoshikawa, an h-index of 31, ranking #1,717,004 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroo Yoshikawa. Posts are plain text and can be reported.